The review found that psychological and pharmacological therapies had similar efficacies in the short-term treatment of depressive disorders. Despite some limitations in the reporting of the review, the authors' main conclusions are likely to be reliable.
To determine the relative efficacy of psychological and pharmacological therapies in the treatment of mild to moderate depression in adults.
Searching
MEDLINE, PsycINFO, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched (1966 ( to May 2007 without language restrictions. Brief search terms were reported in the review. Bibliographies of 22 meta-analyses of psychological treatment for depression were handsearched for additional studies.
Study selection
Randomised controlled trials (RCTs) that compared a pharmacological with a psychological therapy in the treatment of depressive disorders in adults were eligible for inclusion. Studies of patients with depressive symptoms, but not a diagnosis of depression, and those of relapse prevention or maintenance treatment were not eligible.
In the included trials, most participants were a general adult population, though some trials included only elderly, female or patients with multiple sclerosis. Participants were identified through a combination of clinical referrals, community samples and other methods. Most studies included patients with a major depressive disorder; the remainder included patients with dysthymia and/or mild depressive disorder. Definitions of depression for each study were given in the review. The psychological treatments included a variety of types of therapy; details were given in the review. Where reported, the number of sessions ranged from six to 24. The most common pharmacological treatments were selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants. Outcomes were scored on one or more standard rating scales, listed in the review. Trials were conducted in North America, Mexico and the United Kingdom, and ranged in size from 20 to 454 patients.
The authors did not state how many reviewers selected the trials.
Assessment of study quality
Quality was assessed based on three criteria: independent randomisation; blinding of outcome assessors and completeness of outcome data; or the use of intention-to-treat analysis. The authors did not report how many reviewers assessed validity.
Data extraction
The mean post-test scores for the intervention and control groups were extracted to calculate a Cohen's d effect size (standardised mean difference), with a 95% confidence interval (CI). Effect sizes of 0.8 were defined as large, 0.5 as moderate and 0.2 as small. More than one outcome measure was used, a mean effect size per trial (or contrast group) was calculated.
Methods of synthesis
Pooled mean effect sizes (d) were calculated using random-effects models. The authors reported that the results from fixed-effect models were similar. Heterogeneity was assessed using the Q statistic and Ι². Meta-regression was used to assess whether there was an association between key variables and effect size. Subgroup analyses included analyses of studies of patients with major depressive disorder, and severity of depression at baseline. Drop-out rate was assessed using a pooled odds ratio (OR) and 95% confidence interval. Publication bias was assessed using visual inspection of
